HeartFlow
Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.
HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.
At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.
Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com
Transformational data and new paradigms: evaluating stable chest pain with CCTA (World Heart Day Webinar)
In recognition of World Heart Day, an expert panel of cardiologists reviewed the latest data and strategies for improving the diagnosis and management of coronary artery disease (CAD) and data-based benefits of a CCTA-first pathway. Dr. James Udelson (Tufts University, MA, USA), Dr. Michelle Kelsey (Duke University, NC, USA), and Dr. Timothy Fairbairn (Liverpool Heart and Chest Hospital, Liverpool, UK) provide education to achieve these learning objectives:
- Increasing global awareness for advances in cardiovascular disease diagnosis, specifically CAD
- Sharing the latest data on why to choose a CCTA-first pathway for patients with stable chest pain
- Discussing strategies to safely defer testing in low-risk patients
- Exploring patient benefits of the CCTA+FFRCT diagnostic pathway
- Understanding how the CCTA pathway enables clinicians to make more informed and expedited patient care decisions
- Defining methods to improve cath lab efficiency and reduce unnecessary CV tests
